Skip to content

13F-HR filed by Aquilo Capital Management, LLC

Aquilo Capital Management, LLC filed this 13F-HR for the quarter ended 2024-06-30, filed 2024-08-14, with 13 holding rows worth $103,725,464.

Accession
0001591986-24-000006
Filed
2024-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2024

A holdings report, 13 entries on the cover page, a total value of $103,725,464 stated on the cover page (in dollars after the unit check, H1), rows summing to $103,725,464 with VALUE read as dollars as filed, 13F file number 028-18892. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ARROWHEAD PHARMACEUTICALS IN04280A100COM908,474$23,611,239dollars as filed
BLUEPRINT MEDICINES CORP09627Y109COM114,600$12,351,588dollars as filed
ARVINAS INC04335A105COM428,766$11,413,751dollars as filed
REGENXBIO INC75901B107COM906,248$10,603,102dollars as filed
KYMERA THERAPEUTICS INC501575104COM328,743$9,812,979dollars as filed
SILENCE THERAPEUTICS PLC82686Q101ADS500,214$9,504,066dollars as filed
MERUS N VN5749R100COM148,109$8,763,610dollars as filed
PRECISION BIOSCIENCES INC74019P207COM NEW381,803$3,714,943dollars as filed
BICYCLE THERAPEUTICS PLC-ADR088786108SPONSORED ADS156,692$3,171,446dollars as filed
REPARE THERAPEUTICS INC760273102COM956,932$3,157,876dollars as filed
ADICET BIO INC007002108COM2,531,194$3,062,745dollars as filed
IMMATICS N.VN44445109SHS200,000$2,324,000dollars as filed
SUTRO BIOPHARMA INC869367102COM762,498$2,234,119dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001591986-24-000006this filing2024-08-14acceptance time not in the bulk data set